Radiation Oncology

Latest News

Phase 3 data affirm the use of partial-breast intensity-modulated radiotherapy as a standard of care in patients with low-risk early-stage breast cancer.
Partial-Breast Radiation Appears Effective, Safe in Early Breast Cancer

July 7th 2025

Phase 3 data affirm the use of partial-breast intensity-modulated radiotherapy as a standard of care in patients with low-risk early-stage breast cancer.

New ASTRO Guidelines Highlight RT in WHO Grade 4 Adult-Type Diffuse Glioma
New ASTRO Guidelines Highlight RT in WHO Grade 4 Adult-Type Diffuse Glioma

July 6th 2025

No tracer-related adverse effects were observed in the study, with [18F]AIF-NOTA-PCP2 showing acceptable dosimetry in patients with head and neck cancers.
[18F]AIF-NOTA-PCP2 Shows PD-L1 Monitoring Potential in Head and Neck Cancer

July 6th 2025

Data support incorporating volumetric PET biomarkers into toxicity risk prediction for patients receiving CAR T-cell therapy for LBCL.
High Tumor Volume Confers CAR T-Cell Therapy Toxicity Risk in LBCL

June 30th 2025

Compared with 18F-FDG, the use of 68Ga-NODAGA-LM3 appears to favor bone and brain lesion detection among patients with small cell lung cancer.
68Ga-NODAGA-LM3 May Effectively Evaluate Small Cell Lung Cancer Responses

June 28th 2025

Latest CME Events & Activities

26th Annual International Lung Cancer Congress®

July 25-26, 2025

Register Now!

PER's Satellite Symposia at MHS

August 1-2, 2025

Register Now!

20th Annual New York Lung Cancers Symposium®

November 15, 2025

Register Now!

2nd Annual Hawaii Cancer Conference

January 24-25, 2026

Register Now!

19th Annual New York GU Cancers Congress™

March 13-14, 2026

Register Now!

Community Practice Connections™: Empowering Interventional Radiologists in the Emerging Era of Oncolytic Immunotherapies for Melanoma

View More

PER Tumor Board®: Applying Recent Advances to Transform the Treatment Paradigm in SCLC—Expert Perspectives on New Approvals and Emerging Strategies

View More

<1
...
34567